William Cruz‐Muñoz

3.1k total citations · 1 hit paper
23 papers, 2.5k citations indexed

About

William Cruz‐Muñoz is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William Cruz‐Muñoz has authored 23 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William Cruz‐Muñoz's work include Cancer Cells and Metastasis (6 papers), Brain Metastases and Treatment (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). William Cruz‐Muñoz is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Brain Metastases and Treatment (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). William Cruz‐Muñoz collaborates with scholars based in Canada, United States and Italy. William Cruz‐Muñoz's co-authors include Robert S. Kerbel, Christina R. Lee, John M.L. Ebos, James G. Christensen, Georg A. Bjarnason, Shan Man, Rama Khokha, Giulio Francia, Ping Xu and Ping Xu and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and PLoS ONE.

In The Last Decade

William Cruz‐Muñoz

23 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

2009 1.4k citations John M.L. Ebos, Christina R. Lee et al. Cancer Cell profile →

Peers

Countries citing papers authored by William Cruz‐Muñoz

Since Specialization

Citations

This map shows the geographic impact of William Cruz‐Muñoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Cruz‐Muñoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Cruz‐Muñoz more than expected).

Fields of papers citing papers by William Cruz‐Muñoz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Cruz‐Muñoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Cruz‐Muñoz. The network helps show where William Cruz‐Muñoz may publish in the future.

Co-authorship network of co-authors of William Cruz‐Muñoz

This figure shows the co-authorship network connecting the top 25 collaborators of William Cruz‐Muñoz. A scholar is included among the top collaborators of William Cruz‐Muñoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Cruz‐Muñoz. William Cruz‐Muñoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis 2022 ·Small ·Worapol Ngamcherdtrakul, Daniel S. Bejan, William Cruz‐Muñoz, Moataz Reda, (unknown), Natnaree Siriwon, (unknown), Ruijie Wang, Molly A. Nelson, (unknown), Joe W. Gray, Kullervo Hynynen, Wassana Yantasee	42
2	Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis (Small 11/2022) 2022 ·Small ·Worapol Ngamcherdtrakul, Daniel S. Bejan, William Cruz‐Muñoz, Moataz Reda, (unknown), Natnaree Siriwon, (unknown), Ruijie Wang, Molly A. Nelson, (unknown), Joe W. Gray, Kullervo Hynynen, Wassana Yantasee	1
3	Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer 2020 ·npj Breast Cancer ·Kabir A. Khan, (unknown), Madeleine Benguigui, Ping Xu, Annabelle Chow, William Cruz‐Muñoz, Shan Man, Yuval Shaked, Robert S. Kerbel	28
4	Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion 2019 ·PLoS ONE ·Raquel Muñoz, Denise Hileeto, William Cruz‐Muñoz, Geoffrey A. Wood, Ping Xu, Shan Man, Alicia Viloria‐Petit, Robert S. Kerbel	6
5	PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis 2014 ·Clinical Cancer Research ·Lucia B. Jilaveanu, Fabio Parisi, Meaghan L. Barr, Christopher R. Zito, William Cruz‐Muñoz, Robert S. Kerbel, David L. Rimm, Marcus Bosenberg, Ruth Halaban, Yuval Kluger, Harriet M. Kluger	57
6	Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer 2014 ·Angiogenesis ·William Cruz‐Muñoz, Teresa Di Desidero, Shan Man, Ping Xu, María Jaramillo, Kae Hashimoto, Catherine Collins, M. Banville, Maureen D. O'Connor‐McCourt, Robert S. Kerbel	17
7	Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy 2014 ·EMBO Molecular Medicine ·John M.L. Ebos, Michalis Mastri, Christina R. Lee, Amanda Tracz, John M. Hudson, Kristopher Attwood, William Cruz‐Muñoz, Christopher Jedeszko, Peter N. Burns, Robert S. Kerbel	33
8	Abstract 3142: Derivation and analysis of preclinical models of human her-2 positive breast cancer 2014 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ping Xu, William Cruz‐Muñoz, Shan Man, Robert S. Kerbel, Giulio Francia	1
9	Roles for Endothelin Receptor B and BCL2A1 in Spontaneous CNS Metastasis of Melanoma 2012 ·Cancer Research ·William Cruz‐Muñoz, María Jaramillo, Shan Man, Ping Xu, M. Banville, Catherine Collins, André Nantel, Giulio Francia, Sherif S. Morgan, Lee D. Cranmer, Maureen D. O'Connor‐McCourt, Robert S. Kerbel	49
10	Development of preclinical models of human BT474 and MDA-MB-361 breast cancer that endogenously overexpress HER2 and that respond to trastuzumab. 2012 ·Journal of Clinical Oncology ·Giulio Francia, (unknown), Ping Xu, Shan Man, William Cruz‐Muñoz, Guido Bocci, Robert S. Kerbel	1
11	Mouse models of advanced spontaneous metastasis for experimental therapeutics 2011 ·Nature reviews. Cancer ·Giulio Francia, William Cruz‐Muñoz, Shan Man, Ping Xu, Robert S. Kerbel	293
12	Preclinical approaches to study the biology and treatment of brain metastases 2010 ·Seminars in Cancer Biology ·William Cruz‐Muñoz, Robert S. Kerbel	42
13	Potent Preclinical Impact of Metronomic Low-Dose Oral Topotecan Combined with the Antiangiogenic Drug Pazopanib for the Treatment of Ovarian Cancer 2010 ·Molecular Cancer Therapeutics ·Kae Hashimoto, Shan Man, Ping Xu, William Cruz‐Muñoz, Terence Tang, Rakesh Kumar, Robert S. Kerbel	86
14	Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis breakdown → 2009 ·Cancer Cell ·John M.L. Ebos, Christina R. Lee, William Cruz‐Muñoz, Georg A. Bjarnason, James G. Christensen, Robert S. Kerbel	1383
15	Effective Treatment of Advanced Human Melanoma Metastasis in Immunodeficient Mice Using Combination Metronomic Chemotherapy Regimens 2009 ·Clinical Cancer Research ·William Cruz‐Muñoz, Shan Man, Robert S. Kerbel	28
16	The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis 2008 ·Critical Reviews in Clinical Laboratory Sciences ·William Cruz‐Muñoz, Rama Khokha	106
17	Development of a Preclinical Model of Spontaneous Human Melanoma Central Nervous System Metastasis 2008 ·Cancer Research ·William Cruz‐Muñoz, Shan Man, Ping Xu, Robert S. Kerbel	94
18	Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice 2007 ·Molecular Cancer Therapeutics ·Urban Emmenegger, Yuval Shaked, Shan Man, Guido Bocci, Ivan Spasojević, Giulio Francia, Andrew Kouri, (unknown), William Cruz‐Muñoz, Susan M. Ludeman, O. Michael Colvin, Robert S. Kerbel	37
19	Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3−/− mice 2006 ·Oncogene ·William Cruz‐Muñoz, (unknown), (unknown), (unknown), Rićhard P. Hill, Rama Khokha	43
20	TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis 2005 ·Oncogene ·William Cruz‐Muñoz, (unknown), Rama Khokha	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact